Studies find people with schizophrenia are more likely to have low levels of vitamin D Vitamin D-deficient individuals are twice as likely to be diagnosed with schizophrenia as people who have sufficient levels of the vitamin, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism (JCEM). Vitamin D helps the … Continue reading Vitamin D Deficiency Raises Risk of Schizophrenia Diagnosis
All posts by dhtest
New Happy Patient Index Ranks Best & Worst U.S. Cities by Physician Reviews
Unprecedented analysis of online reviews of 46,300 doctors finds harshest critics in New York & California – and the happiest patients in California, too
57% of Type 1s Expect a Cure by 2024
New York, NY (PRWEB)–More than half of people who have type 1 diabetes or have a family member or close friend with the disease expect a cure to be found in the next 10 years, according to a semi-annual survey conducted by the Juvenile Diabetes Cure Alliance. The findings, outlined in a new report a … Continue reading 57% of Type 1s Expect a Cure by 2024
Successful Clinical Trial of Type 2 Drug That Works on Intestinal Organisms
BROOMFIELD, Colo.–MicroBiome TherapeuticsTM has announced positive results from its clinical trial of a microbiome modulator, NM504, in development for type 2 diabetes and pre-diabetes. NM504 is designed to improve glucose tolerance and other metabolic parameters in patients with diabetes by shifting the gastrointestinal microbiome–the micro-organisms that inhabit the human body. Studies have shown that people … Continue reading Successful Clinical Trial of Type 2 Drug That Works on Intestinal Organisms
FDA Approves Dexcom G4 Platinum CGM Use for Children 2-17
The U.S. Food and Drug Administration has approved the expanded use of the Dexcom G4 Platinum Continuous Glucose Monitoring System for patients with diabetes ages 2 to 17 years. The G4 Platinum System, which monitors blood glucose levels in people with diabetes, had been approved for patients ages 18 and older. The FDA has not … Continue reading FDA Approves Dexcom G4 Platinum CGM Use for Children 2-17
Novo Announces U.S. Launch of NovoPen Echo
Plainsboro, N.J.–Novo Nordisk has announced the U.S. launch of its NovoPen Echo® insulin delivery device. It is the first and only pen device available in this country with half-unit dosing and a memory function that records the dose and time passed since the last injection. “We believe this pen can help patients fine-tune their dosing … Continue reading Novo Announces U.S. Launch of NovoPen Echo
NCPA Supports Senate Bill Allowing Pharmacy Deliveries of Diabetes Testing Supplies
ALEXANDRIA, VA–New legislation to allow independent community pharmacies to provide same-day delivery of diabetes testing supplies to Medicare beneficiaries should be enacted into law, the National Community Pharmacists Association is urging. The Diabetic Testing Supply Access Act (S. 1935) was introduced January 16 by U.S. Senators Jerry Moran (R-Kan.) and John Thune (R-S.D.). Since July … Continue reading NCPA Supports Senate Bill Allowing Pharmacy Deliveries of Diabetes Testing Supplies
Tandem Diabetes Care Recalls Some t:slim Insulin Pump Cartridges
San Diego-based Tandem Diabetes Care®, Inc. announced Friday that it is voluntarily recalling specific lots of insulin cartridges that are used with the t:slim® Insulin Pump. The affected cartridges may be at risk for leaking. Tandem will provide replacement cartridges to its customers at no charge. The company identified the potential problem during internal product … Continue reading Tandem Diabetes Care Recalls Some t:slim Insulin Pump Cartridges
Nipro Diagnostics Recalls Certain TRUEbalance and TRUEtrack Meters
Nipro Diagnostics, Inc. today announced it is initiating a voluntary recall and replacement of a limited number of TRUEbalanceTM and TRUEtrack® Blood Glucose Meters distributed both in and outside the United States. The company has determined that certain isolated TRUEbalance and TRUEtrack Blood Glucose Meters distributed in the United States have an incorrect factory-set unit … Continue reading Nipro Diagnostics Recalls Certain TRUEbalance and TRUEtrack Meters
Global CGM Market Will Reach $568.5 Million by 2020
PRNewswire–According to a new market research report, the global continuous glucose monitoring market is projected to reach $568.5 million by 2020–up significantly from the 2012 figure of $194.8 million due to a projected compound annual growth rate of 14.8 percent. The report, from Allied Market Research, is titled “Continuous Glucose Monitoring Market (CGM Systems, Application, … Continue reading Global CGM Market Will Reach $568.5 Million by 2020
